AI Cardiovascular Screening System Market to Reach USD 3.20 Billion by 2034

I
intel Akash

According to a new report from Intel Market Research, the global AI Cardiovascular Screening System market was valued at USD 580 million in 2025 and is projected to reach USD 3 200 million by 2034, growing at a robust CAGR of 27.5% during the forecast period (2026–2034). This expansion is driven by the escalating prevalence of cardiovascular disease-now affecting more than 530 million people worldwide-and the accelerating adoption of AI‑enabled preventive cardiology tools across hospital networks and primary‑care settings.

AI Cardiovascular Screening System solutions leverage cutting‑edge artificial‑intelligence models that ingest echocardiography images, vascular ultrasound scans, ECG waveforms and continuous vital‑sign feeds to uncover early cardiac risk patterns. By automating view selection, providing precise chamber dimension measurements, and generating surrogate ejection‑fraction estimates, these platforms dramatically compress triage timelines while preserving diagnostic fidelity.

📥 Download FREE Sample Report:
AI Cardiovascular Screening System Market - View in Detailed Research Report

Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.

Comments

Back to TalkMarkets